Comparative Pharmacology
Head-to-head clinical analysis: GLYCOLAX versus GO EVAC.
Peer-Reviewed Evidence
Head-to-head clinical analysis: GLYCOLAX versus GO EVAC.
GLYCOLAX vs GO-EVAC
Comparing the clinical profiles, pharmacokinetic behaviors, and safety indices of these two therapeutic agents.
Osmotic laxative. Polyethylene glycol (PEG) increases intraluminal water volume in the colon by osmosis, promoting stool passage and relieving constipation.
Promotes gastrointestinal motility by acting as a stimulant laxative, likely through direct irritation of the colonic mucosa and possibly via local effects on enteric neurons.
17 g (1 heaping tablespoon) dissolved in 4-8 ounces of liquid once daily, orally.
10 mg orally once daily, with or without food.
None Documented
None Documented
Not applicable due to negligible systemic absorption; local colonic transit time approximately 2-4 hours.
4.5-6 hours in healthy volunteers; prolonged to 10-14 hours in elderly patients and those with moderate renal impairment (CrCl 30-50 mL/min).
Minimally absorbed; excreted primarily unchanged in feces via osmotic action. Renal excretion negligible (<0.2% absorbed dose).
Primarily renal; approximately 60% eliminated unchanged in urine within 24 hours, with 20% as metabolites. Biliary/fecal excretion accounts for 15-20%, and the remainder is metabolized via glucuronidation.
Category C
Category C
Osmotic Laxative
Osmotic Laxative